Continuation of Systemic Treatments and Outcomes for Patients with Chronic Graft-Versus-Host Disease in the USA

References

• Flowers ME , MartinPJ. How we treat chronic graft-versus-host disease. Blood125(4), 606–615 (2015).
   PubMed Web of Science ®Google Scholar
• Jones CA , FenandezLP , WeimersheimerPet al. Estimating the burden of cost in chronic graft-versus-host disease: a human capital approach. J. Health Eco. Out. Res.4(2), 5 (2016).
   Google Scholar
• Ferrara JL , LevineJE , ReddyP , HollerE. Graft-versus-host disease. Lancet373(9674), 1550–1561 (2009).
   PubMed Web of Science ®Google Scholar
• Baker KS , GurneyJG , NessKKet al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood104(6), 1898–1906 (2004).
   PubMed Web of Science ®Google Scholar
• Bhatia S , FranciscoL , CarterAet al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood110(10), 3784–3792 (2007).
   PubMed Web of Science ®Google Scholar
• Flowers MED , ParkerPM , JohnstonLJet al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood100(2), 415–419 (2002).
   PubMed Web of Science ®Google Scholar
• Filipovich AH , WeisdorfD , PavleticSet al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol. Blood Marrow Transplant.11(12), 945–956 (2005).
   PubMed Web of Science ®Google Scholar
• Flowers MED , StorerB , CarpenterPet al. Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease. Biol. Blood Marrow Transplant.14(12), 1380–1384 (2008).
   PubMed Web of Science ®Google Scholar
• Inamoto Y , FlowersMED , SandmaierBMet al. Failure-free survival after initial systemic treatment of chronic graft-versus-host disease. Blood124(8), 1363–1371 (2014).
   PubMed Web of Science ®Google Scholar
• Xia CQ , CampbellKA , Clare-SalzlerMJ. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells. Curr. Opin. Organ Transplant.14(4), 338–343 (2009).
   PubMed Web of Science ®Google Scholar
• Garnett C , ApperleyJF , PavlůJ. Treatment and management of graft-versus-host disease: improving response and survival. Ther. Adv. Hematol.4(6), 366–378 (2013).
   PubMedGoogle Scholar
• Wolff D , SchleuningM , Von HarsdorfSet al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol. Blood Marrow Transplant.17(1), 1–17 (2011).
   PubMed Web of Science ®Google Scholar
• Cho A , JantschitschC , KnoblerR. Extracorporeal photopheresis-an overview. Front Med. (Lausanne)5, 236 (2018).
   PubMed Web of Science ®Google Scholar
• Schmitt DA , UllrichSE. Exposure to ultraviolet radiation causes dendritic cells/macrophages to secrete immune-suppressive IL-12p40 homodimers. J. Immunol.165(6), 3162–3167 (2000).
   PubMed Web of Science ®Google Scholar
• Fadok VA , BrattonDL , KonowalA , FreedPW , WestcottJY , HensonPM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest.101(4), 890–898 (1998).
   PubMed Web of Science ®Google Scholar
• Couriel DR , HosingC , SalibaRet al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood107(8), 3074–3080 (2006).
   PubMed Web of Science ®Google Scholar
• Marshall SR . Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?. Nat. Clin. Pract. Oncol.3(6), 302–314 (2006).
   PubMedGoogle Scholar
• Phurrough S , SaliveM , HarrisonSet al. Proposed decision memo for extracorporeal photopheresis (CAG-00324R). www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=180&ExpandComments=n&ver=6&CALId=88&CalName=Blood+Counts+ December 5 (2006).
   Google Scholar
• Stewart BL , StorerB , StorekJet al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood104(12), 3501–3506 (2004).
   PubMed Web of Science ®Google Scholar
• Mehta S , GhoshS , SanderS , KutiE , MountfordWK. Differences in all-cause health care utilization and costs in a Type 2 diabetes mellitus population with and without a history of cardiovascular disease. J. Manag. Care Spec. Pharm.24(3), 280–290 (2018).
   PubMed Web of Science ®Google Scholar
• Barron JJ , QuimboR , NikamPT , AmonkarMM. Assessing the economic burden of breast cancer in a US managed care population. Breast Cancer Res. Treat.109(2), 367–377 (2008).
   PubMed Web of Science ®Google Scholar
• Strens DEA . Healthcare costs of patients with acute and chronic graft-versus-host disease following allogeneic haematopoietic stem cell transplantation in Belgium: a retrospective data collection and analysis. Value Health20(Issue 9), A578 (2017).
   Web of Science ®Google Scholar
• Yu J , ParasuramanS , ShahA , WeisdorfD. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation. Curr. Med. Res. Opin.35(6), 983–988 (2019).
   PubMed Web of Science ®Google Scholar
• De Waure C , CapriS , VenezianoMAet al. Extracorporeal photopheresis for second-line treatment of chronic graft-versus-host diseases: results from a health technology assessment in Italy. Value Health18(4), 457–466 (2015).
   PubMed Web of Science ®Google Scholar
• Curtis LM , PirslF , SteinbergSMet al. Predictors for permanent discontinuation of systemic immunosuppression in severely affected chronic graft-versus-host disease patients. Biol. Blood Marrow Transplant.23(11), 1980–1988 (2017).
   PubMed Web of Science ®Google Scholar